Program Schedule

1127
Seroconversion for Cytomegalovirus in a Canadian Cohort of Pregnant Women

Session: Poster Abstract Session: Viral Infections: Epidemiology
Friday, October 10, 2014
Room: The Pennsylvania Convention Center: IDExpo Hall BC
Posters
  • Poster_cmv_2oct2014.pdf (2.1 MB)
  • Background: Cytomegalovirus (CMV) is the leading cause of congenital infection and non-genetic sensorineuronal hearing loss in children. CMV primo-infection occurring during pregnancy has the highest risk of symptomatic infection in the newborn. There are no recent data on the incidence of CMV infection during pregnancy in Canada.

    Methods: This study used serum samples and questionnaire data collected as part of the 3D Pregnancy and Birth Cohort Study (Quebec, Canada, 2010-2013) designed to investigate the effect of a range of prenatal factors on birth outcomes. Consent allowed for subsequent use of data and biobanked biological specimens. Women who had serum banked from both the end of the first trimester and the third trimester were included. Serum CMV IgG antibodies were determined. Women who were seronegative in early pregnancy had their late serum tested to determine conversion rates. Associations between independent variables and seroprevalence were assessed using logistic regression, and associations with seroconversions, by Poisson regression. 

    Results: Of 1938 subjects tested in early pregnancy, 1156 (59.6%) were seronegative for CMV, and 35 seroconverted (3.0%) by the end of pregnancy. The seroconversion rate was 2.0 (95% CI 1.4-2.8) per 10, 000 person-days at risk or 5.7 (95% CI 4.0-7.9) per 100 pregnancies assuming a 280-day gestation. Maternal factors independently associated with seropositivity were working as a daycare educator or a kindergarten teacher (OR= 5.0, 95% CI 1.8-13.9), first language other than French or English (OR = 4.0, 95% CI 2.7-5.5), being born outside Canada or USA (OR = 4.0, 95% CI 2.9-5.3), lower education (primary or secondary vs. university, OR = 2.6, 95% CI 1.8-3.7), and having had children  (OR 1.3, 95% CI 1.1-1.7). Among initially seronegative pregnant women, those born outside Canada or USA were at higher risk of seroconversion (RR = 3.1, 95% CI 1.3-7.3).

    Conclusion: Nearly 60% of pregnant women in this cohort were susceptible to CMV in early pregnancy.  Overall seroconversion rates approaching 6% are of concern with seronegative women born outside Canada and the USA being at higher risk; targeted interventions may be needed in this group. Further data are needed on the effectiveness of public health prevention strategies.

    Valérie Lamarre, MD, Pediatrics, Infectious Diseases, CHU Sainte-Justine, Université de Montréal, Montreal, QC, Canada, Nicolas L. Gilbert, M.Sc, Maternel and Infant Health Section, Public Health Agency of Canada, Ottawa, ON, Canada, Céline Rousseau, MD, Department of Microbiology and Immunology, CHU Sainte-Justine – University of Montreal, Montreal, QC, Canada, Theresa W. Gyorkos, PhD, Epidemiology, Biostatistics and Occupational Health, McGill university, Montreal, QC, Canada and William D. Fraser, MD, Obstetric and Gynaecology, Centre de Recherche CHUS (Université de Sherbrooke), Sherbrooke, QC, Canada

    Disclosures:

    V. Lamarre, None

    N. L. Gilbert, None

    C. Rousseau, None

    T. W. Gyorkos, None

    W. D. Fraser, None

    Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

    Sponsoring Societies:

    © 2014, idweek.org. All Rights Reserved.

    Follow IDWeek